Blood Cancer Drugs Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 25
SKU : PH3416
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Blood Cancer Drugs Market ?
Global Blood Cancer Drugs Market size reached USD 63 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 113.5 billion by 2031
Who are the Key Players of Blood Cancer Drugs Market?
Major players are Amgen Inc., AstraZeneca Plc, Takeda Pharmaceutical Company Ltd, Bayer AG, Celgene Corporation, Eli Lilly, Bristol-Myers Squibb Company, Gilead Sciences Inc., Daiichi Sankyo Company Ltd and UCB SA.
Related Reports
pharmaceuticalsLeukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 05
Starting from
$4350
pharmaceuticalsCancer Stem Cell Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 21
Starting from
$4350
pharmaceuticalsAcute Lymphocytic Leukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 22
Starting from
$4350
pharmaceuticalsCancer Angiogenesis Inhibitors Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 24
Starting from
$4350
pharmaceuticalsSkin Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 01
Starting from
$4350
pharmaceuticalsNon Melanoma Skin Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 23
Starting from
$4350